Virtual Reality in Orthopedic Rehabilitation

Sponsor
Joanna Szczepańska-Gieracha (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT06002139
Collaborator
Wroclaw Medical University (Other), Wroclaw University of Health and Sport Sciences (Other), Jan Dlugosz University in Czestochowa (Other)
68
1
2
4
17

Study Details

Study Description

Brief Summary

The study's objective is to evaluate the efficacy of implemented Virtual Reality therapy for patients who have undergone lower limb arthroplasty and are in inpatient rehabilitation. We aim to examine its influence on reducing anxiety levels, mitigating depressive symptoms, enhancing motivation for elderly patients to participate in physiotherapy, and improving their overall functional state and fall risk.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Immersive Virtual Reality Therapy
  • Behavioral: Conventional rehabilitation
N/A

Detailed Description

The study will include elderly patients (60+) who present sequentially at the General Systemic Rehabilitation Department of St. Hedwig of Silesia Hospital in Trzebnica, within 3 months of having undergone hip or knee joint arthroplasty surgery. Patients will be randomly assigned to one of two groups: A. Virtual Reality Group: 8 therapy sessions, two sessions per week; B. Control group, undergoing conventional rehabilitation. Participation in the study is entirely voluntary, and written consent is required.

Study Design

Study Type:
Interventional
Actual Enrollment :
68 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Does Immersive Virtual Reality Therapy Support Orthopedic Rehabilitation? A Randomized-Controlled Trial
Actual Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Oct 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Immersive Virtual Reality Therapy

Conventional orthopedic rehabilitation supplemented by VR therapy

Behavioral: Immersive Virtual Reality Therapy
8 sessions of VR therapy over 4 weeks (each of them 20 minutes long). As a virtual reality source, VRTierOne device (Stolgraf®) were used. Thanks to using head mounted display and the phenomenon of total immersion VR therapy provides an intense visual, auditory and kinesthetic stimulation. It can have a calming and mood-improving effect or help the patients recognize their psychological resources and motivate to the rehabilitation process. In the virtual therapeutic garden there are a rich set of symbols and metaphors based on Ericksonian Psychotherapy approach. The most important is the Garden of Revival which symbolizes the patient's health. It used to be full of life and energy, now it is neglected, requires work to be revived. In the therapeutic process day by day, the therapist tells the patient a symbolic story about his/her situation.

Behavioral: Conventional rehabilitation
Four weeks of conventional rehabilitation including: Two hours of kinesiotherapy (120 minutes, including gait training). Thirty minutes of ergotherapy. Three physical therapy procedures (i.e. laser therapy, magnetic therapy, electrotherapy) tailored to individual ailments and needs.

Active Comparator: Conventional rehabilitation

Conventional orthopedic rehabilitation

Behavioral: Conventional rehabilitation
Four weeks of conventional rehabilitation including: Two hours of kinesiotherapy (120 minutes, including gait training). Thirty minutes of ergotherapy. Three physical therapy procedures (i.e. laser therapy, magnetic therapy, electrotherapy) tailored to individual ailments and needs.

Outcome Measures

Primary Outcome Measures

  1. Hospital Anxiety and Depression Scale (HADS) [15 minutes]

    The Hospital Anxiety and Depression Scale (HADS) is a fourteen-item scale scoring from 0 to 3 for each item. The first seven items relate to anxiety (HADS-A), and the remaining seven items relate to depression (HADS-D). The global scoring ranges from 0 to 42 with a cut-off point of 8/21 for anxiety and 8/21 for depression. The higher the score, the greater anxiety or depression symptoms.

  2. Perceived Stress Scale (PSS-10) [10 minutes]

    The Perceived Stress Scale (PSS-10) is a ten-item scale that assesses the level of stress perceived by an individual in the last month. The questions are general in nature and fairly free of content specific to any subpopulation group. The items are designed to tap into how unpredictable, uncontrollable, and overloaded respondents find their lives to be. The scores range from 0 to 40, with higher scores indicating higher perceived stress. The PSS-10 will be administered at the beginning and after four weeks of treatment.

Secondary Outcome Measures

  1. Generalized Self-Efficacy Scale (GSES) [15 minutes]

    The Generalized Self-Efficacy Scale (GSES) is a ten-item psychometric scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life. The scale measures the belief in one's competence to cope with a broad range of stressful or challenging demands. The score ranges from 10 to 40, with a higher score indicating a greater sense of self-efficacy. The GSES will be applied at the beginning and after four weeks of treatment.

  2. Barthel Index (BI) [15 minutes]

    The Barthel Index (BI) is an ordinal scale used to measure performance in activities of daily living (ADL). Each performance item is rated on this scale with a given number of points assigned to each level or ranking. It uses ten variables describing ADL and mobility. A higher number is associated with a greater likelihood of being able to live at home with a degree of independence following discharge from the hospital. The BI will be administered at the beginning and after four weeks of treatment.

  3. Rivermead Mobility Index (RMI) [15 minutes]

    The Rivermead Mobility Index (RMI) was developed from the Rivermead Motor Assessment Gross Function subscale as a means to quantify mobility disability. It is composed of 14 items representing different mobility tasks, ranging from turning over in bed to running. Each item is scored as 'unable' (0) or 'able' (1), leading to a maximum score of 14, which indicates full mobility. The RMA-GF will be administered at the beginning and after four weeks of treatment.

  4. Tinetti's Short Scale [15 minutes]

    Tinetti's Short Scale for fall risk assessment is a shortened version of Performance-Oriented Mobility Assessment (POMA). It is easily administered test that measures a patient's gait and balance. The test is scored on the patient's ability to perform following tasks:Change from sitting to standing, Immobilization in standing position for 5 seconds, Passing 3 meters, Turn of 180 degrees, Keeping a sitting position. Each task is rated in 3-point Likert scale.

  5. Short Physical Performance Battery (SPPB) [15 minutes]

    The Short Physical Performance Battery (SPPB) is a group of measures that combines the results of the gait speed, chair stand and balance tests. It provides a composite score ranging from 0 (worst performance) to 12 (best performance), offering a global assessment of physical functioning in older individuals. The SPPB will be administered at the beginning and after four weeks of treatment.

  6. Perception of Stress Questionnaire (PSQ) [20 minutes]

    The PSQ was created by Plopa and Makarowski. It is a 27-item scale scoring from 1 to 5 points for each item, where 21 items examine the level of stress in the areas of emotional tension, external stress and intrapsychic stress, and six items refer to the lie scale. The global scoring for the perception of stress ranges from 21 to 105, with a cut-off point of 60 for an elevated level of perceived stress.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Individuals who have recently undergone hip or knee joint arthroplasty surgeries aged 60 years and above.
Exclusion Criteria:
  • cognitive impairments that prevent independent completion of research questionnaires

  • reported consciousness disorders

  • bipolar affective disorder and other serious mental disorders in the patient's medical history

  • use of psychoactive drugs

  • ongoing psychiatric treatment or individual psychological therapy

  • contraindications to Virtual Reality such as epilepsy, vertigo, serious vision disorders

  • functional status preventing independent movement (orthopedic aids are allowed, e.g., crutches, walker)

  • refusal to participate in the study at any stage

Contacts and Locations

Locations

Site City State Country Postal Code
1 St. Hedwig of Silesia Hospital in Trzebnica Trzebnica Lower Silesia Poland 55-100

Sponsors and Collaborators

  • Joanna Szczepańska-Gieracha
  • Wroclaw Medical University
  • Wroclaw University of Health and Sport Sciences
  • Jan Dlugosz University in Czestochowa

Investigators

  • Study Chair: Justyna Mazurek, PhD, Wroclaw Medical University
  • Study Chair: Błażej Cieślik, PhD, Jan Dlugosz University in Czestochowa, Poland
  • Principal Investigator: Justyna Mazurek, RhD, Wroclaw Medical University
  • Study Director: Joanna Szczepańska-Gieracha, Professor, Wrocław University of Health and Sport Sciences
  • Study Director: Robert Gajda, PhD, Gajda-Med District Hospital in Pułtusk

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Joanna Szczepańska-Gieracha, Professor, Wroclaw University of Health and Sport Sciences
ClinicalTrials.gov Identifier:
NCT06002139
Other Study ID Numbers:
  • VRortoTrzebnica
First Posted:
Aug 21, 2023
Last Update Posted:
Aug 21, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Joanna Szczepańska-Gieracha, Professor, Wroclaw University of Health and Sport Sciences
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 21, 2023